A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma

Weijing Sun, Anuj Patel, Daniel Normolle, Krishna Patel, James Ohr, James J. Lee, Nathan Bahary, Edward Chu, Natalie Streeter, Summer Drummond

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences